FITC Mouse Anti-Human HLA-DR Antibody (S-R566)

產(chǎn)品型號：S0B1755

更新時間：2025-07-12

廠商性質(zhì)：生產(chǎn)廠家

訪問量：47

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

FGF19信號通路：從代謝調(diào)控到癌癥治療

泛）修飾抗體與定制服務(wù)，助力PTMs研究

傳染病抗原抗體原料：助力診斷與疫苗開發(fā)

FLAG標(biāo)簽蛋白的結(jié)構(gòu)與功能解析

產(chǎn)品介紹

HLA-DR is a class II Major Histocompatibility Complex （MHC） antigen in human. It is primarily expressed on immune cells, especially dendritic cells and macrophages, and plays a crucial role in recognizing and distinguishing foreign substances from self-tissues. It is involved in regulating the activation status of these cells and plays a key role in immune responses, including anti-infection immunity, tumor immunity, and transplantation immunity. In organ transplantation, HLA-DR is closely related to organ transplant rejection reactions. In the fields of hematopoietic stem cell transplantation and bone marrow transplantation, HLA-DR also plays an important role. Changes in the expression level of HLA-DR are related to the diagnosis of inflammatory diseases, the assessment of severity, and the monitoring of immune status. Unlike other cell activation markers such as CD69, CD25, and CD38, HLA-DR is not expressed on most T cells and is only expressed on a subset of activated T cells during the late stages of an immune response.

上一個：S0B1218Rat Anti-Mouse/Human CD11b Antibody(S-R574)